Summary:
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Materials and Methods
Preparation of nuclear extracts : Placentae of staged mice (8) or other tissues of adult mice were used as a starting material. All steps were carried out on ice. The usual procedure to prepare nuclear extracts was as described (13) with the following modifications: Tissues were removed, immediately washed in 0.14 M NaCI, 10 mM TrisCI pH 8.0 and cut into pieces.
Buffer I was supplemented with 0.1 % Triton X-100. After dialysis against buffer III, precipitates were removed by centrifugation, the supernatants were frozen in liquid N2 a n d afterwards directly used in gel retardation without further column chromatography.
As an alternative method a hypotonic extraction procedure without detergent was used. Tissues were removed, transferred to PBS supplemented with 2 mM MgCl2, 5 mM KCI and minced followed by homogenization in 10 ml/g tissue in the same buffer. The cell suspension was centrifuged for 5 min at 375xg and the pellet lysed in a hypotonic buffer containing 10 mM HEPES pH 8.0, 2 mM MgCla, 5mM KCI, 0.5 mM spermidine (Sigma), 0.15 mM spermine (Sigma), 0.5 mM phenyl-methyl-sulfonylfluoride (PMSF), 7 mM p-mercaptoethanol, 0.25 pglml aprotinin (Sigma), 10 pg/ml leupeptin (Sigma) with15 strokes in a glass potter. Sucrose was slowly added to a final concentration of 0.3 M and the nuclei were centrifuged for 5 min at 9OOxg. The nuclei were washed with hypotonic buffer containing 0.3 M sucrose and pelleted by centrifugation for 5 min at 800xg. The nuclei were then resuspended in 5 to 7 volumes of the pellet in elution buffer ( 10 mM HEPES pH 8.0, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM spermidine, 0.15 mM spermine, 420 mM NaCI, 10 % glycerol, 0.5 mM PMSF, 7 mM f3-mercaptoethanol, 0.25 pg/ml aprotinin, 10 pg/ml leupeptin) and the nuclear proteins eluted for 30 min with occasional shaking. insoluble material was removed by centrifugation at 23000xg for 20 min and the supernatant frozen in liquid N2.
Gel retardation assay : Binding reactions contained 40 mM KCI, 10 mM HEPES pH 7.6, 4 % Ficoll (Pharmacia), 1 mM EDTA, 1 mM DTT, 1 pg poly(dldC) (Pharmacia), 0.5 mM ATP (as cold competitor for free [32Pl-ATP), 5 pg nuclear extract, 0.2 pmole [s2Pl-ATP end-labeled doublestranded probe (specific activity 5 to 7.5 x 107 dpm/yg) and if required, a 250-, 300-or lOOO-fold molar excess of the respective double-stranded unlabeled competitor in a reaction volume of 25 ~1. Pipetting was done on ice followed by a 30 min incubation at room temperature.
Three yl loading buffer were added and the complexes separated on 4 % nondenaturing polyacrylamide gels run in 0.5 x TBE at 12 V/cm. Gels were vacuum dried and autoradiographed using X-ray film.
DNasel hypersensitive site mapping : All steps were carried out on ice. Placentae were removed and homogenized in 30 ml/g tissue buffer B (0.15 mM spermine, 0.5 mM spermidine, 15 mM TrisCI pH 7.5, 60 mM KCI, 15 mM NaCI, 2 mM EDTA, 0.5 mM EGTA, 0.5 M sucrose) with 10 strokes in a glass potter. Cells were centrifuged for 5 min at 15OOxg, resuspended in 20 ml buffer C (buffer B with 0.5 % Triton X-100) and lysed with 10 strokes in a glass potter. Nuclei were pelleted by centrifugation for 5 min at 15OOxg, washed in buffer D (buffer B with 0.35 M sucrose) and the pellet frozen in liquid N2. 5 x 10s nuclei were resuspended in 2.25 ml buffer E (buffer B without sucrose and with 0.2 mM EGTA, 1 mM PMSF) and aliquoted at 250 PI. These aliquots were digested with increasing amounts of DNasel (Worthington) in a total volume of 500 ~1 buffer E for 15 min on ice. Reactions were started by addition of 20 PI MgCl2 (100 mM) and stopped with 10 PI EDTA (0.5 M). The DNasel concentration was increased by doubling the units, starting with 32 units (Fig. 3, lane 3) . Genomic DNA was prepared, digested with BamHl and 6.5 pg per lane were separated on a 1 % agarose gel. The DNA was transferred to Immobilon-NTM and hybridized with a [32Pl-labeled 310 bp Stul/BamHI fragment from Cea-2 comprising most of the second exon (8). Filters were washed in 0.1 x SSPE/O.l YO SDS at 65 "C and autoradiographed at -80 "C using an intensifying screen. (Fig. 1A) . The uppermost complex formed with day 11 placental extract (marked by an arrow) is apparently not present when day 18 nuclear extract is used.
To analyze which part of the conserved region is involved in DNA binding we cut the whole region down to individual subregions using double-stranded oligonucleotides. Interestingly, only the flanking regions A and D gave a retarded protein/DNA complex (Fig. 1B) . The formation of such complexes could be drastically reduced when an excess of the respective unlabeled DNA was added as a competitor to the binding reactions (Fig. 1C) . In Figure 1 D, a competition experiment using a high molar excess of either the specific competitors (A or D, respectively) or oligonucleotide B as a non-specific competitor is shown to rule out non-specific effects. Interestingly, it turned out that the two regions which bind nuclear factors are interchangeable to a certain extent in a competition assay, exhibiting cross-competition of each other (Fig. 1E) . This makes it possible that related or even identical factors take part in complex formation with sequences present in probes A and D. In this context, it should be noted that regions A and D share an identical pentamer sequence which forms an inverted repeat (see Fig. 1 bottom) . Whether such a motif represents a binding site for the putative regulatory factors remains to be shown. To examine whether the expression of such factors is exclusively restricted to placenta or can also be found in other tissues, we tested nuclear extracts from various adult mouse tissues as well as from the human colon adenocarcinoma cell line Lovo and the promyelocytic cell in the gel retardation assay to narrow down the binding region. C, specific competition of complex formation is shown using a 250x molar excess of the indicated unlabeled oligonucleotides. D, the binding specificity of regions A and D is analyzed using a high molar excess (1000x) of either the specific competitors A or D, respectively or of oligonucleotide B as a nonspecific competitor. E , the ability of oligonucleotides A and D to reciprocally compete each other has been tested (300x). Specific complexes are indicated by brackets. The stages of the mouse placental nuclear extracts are indicated above the lanes. In E, nuclear extract from day 16 mouse placenta was used. At the bottom of the figure the sequence of the conserved region of Cea-2 (8) is shown together with the position of the oligonucleotides which have been used in gel retardation. The arrows above the sequence indicate an inverted repeat motif. line HL60. We detected shifts in the mobility of oligonucleotide D with all the extracts tested (Fig. 21, to the conserved region (HSS2 in Fig. 3 ) which correlates well with the in vitro data (see Fig. 1 ). It remains to be shown whether this in viva interaction reflects a repressor activity present at a stage when Cea-2 is not transcribed or the inactive state of this gene is caused by the absence of additional activating factors required at this site. In addition, another hypersensitive site (HSSl in Fig. 3 ) has been found in the first intron of Cea-2 which apparently coincides with a (GGA), simple sequence (unpublished). Simple sequences have been reported for a number of other rodent (7, 8, 11) 
